We demonstrated that CTNNB1 exon3 missense mutations not directly affecting phosphorylation sites but adjacent non-phosphorylation codons, have an equally robust effect on β-catenin activation in HCC patients. Here, CTNNB1 is linked to hepatocellular carcinoma.